The season of Q2 results will continue on Monday as results of 10 major companies (Total-55) are set to release on the day. These entities are from different sectors, including consumer goods, pharmaceuticals, financial services, and banks.
The big names scheduled to announce their Q2 results on Monday are:
- Tata Consumer Products
- REC
- One 97 Communications (Paytm)
- Mankind Pharma
- ITC Hotels
- Supreme Industries
- APL Apollo Tubes
- Dalmia Bharat
- Bank of Maharashtra
- Indian Overseas Bank
Investors will track the companies’ financial performance for the September quarter, including revenue growth, profitability and management commentary, for clues about business trends across sectors.
Meanwhile, REC, Supreme Industries and Dalmia Bharat are also scheduled to consider dividend-related decisions alongside their quarterly results. Investors will watch for announcements from these companies as they review their earnings and capital-return plans.
Besides the above list, the Q2 results of following companies are also expected to arrive on Monday:
Aavas Financiers, Aditya Birla Real Estate, AceVector, Aegis Logistics, Aegis Vopak Terminals, Aequs, Antelopus Selan Energy, Astec LifeSciences, Ather Energy, Avantel, Brigade Hotel Ventures, Cyber Media (India), DCM Shriram, Deepa Jewellers, Dhanlaxmi Bank, DRC Systems India, Eris Lifesciences, Everest Industries, Five-Star Business Finance, Ishan Dyes and Chemicals, JBM Auto, Kfin Technologies, LEAP India, Lumax Industries, Macpower CNC Machines, Nazara Technologies, New Delhi Television, Paramount Communications, PNGS Reva Diamond Jewellery, Music Broadcast, RIR Power Electronics, Shanthi Gears, SMC Global Securities, Sona BLW Precision Forgings, SRIT India, Sumitomo Chemical India, Sunteck Realty, Surana Solar, Tamilnad Mercantile Bank, The Ugar Sugar Works, Venus Remedies, Vidhi Specialty Food Ingredients, Vineet Laboratories, Vinyl Chemicals (India), WeWork India Management.
The results could offer insights into demand trends in consumer goods, performance in the pharmaceutical sector, developments in financial services and activity across industrial businesses.